Journal article
Systematic review and meta-analysis: Prevalence, risk factors, and costs of aminosalicylate use in Crohn’s disease
- Abstract:
-
Background
Aminosalicylates are the most frequently prescribed drugs for patients with Crohn’s disease (CD), yet evidence to support their efficacy as induction or maintenance therapy is controversial.
Aims
To quantify aminosalicylate use in CD clinical trials, identify factors associated with use, and estimate direct annual treatment costs of therapy.
Methods
MEDLINE, Embase, and CENTRAL were searched to April 2017 for placebo-controlled trials in...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Canadian Institutes of Health Research
More from this funder
American College of Gastroenterology
More from this funder
Crohn’s and Colitis Foundation
More from this funder
Canadian Association of Gastroenterology
More from this funder
Bibliographic Details
- Publisher:
- Wiley Publisher's website
- Journal:
- Alimentary Pharmacology & Therapeutics Journal website
- Volume:
- 48
- Issue:
- 2
- Pages:
- 114-126
- Publication date:
- 2018-05-30
- Acceptance date:
- 2018-05-02
- DOI:
- EISSN:
-
1365-2036
- ISSN:
-
0269-2813
- Source identifiers:
-
854304
Item Description
- Keywords:
- Pubs id:
-
pubs:854304
- UUID:
-
uuid:854e71cc-5c35-444d-a242-9713136c5481
- Local pid:
- pubs:854304
- Deposit date:
- 2018-05-31
Terms of use
- Copyright holder:
- Wiley
- Copyright date:
- 2018
- Notes:
- © 2018 John Wiley & Sons Ltd. This is the accepted manuscript version of the article. The final version is available online from Wiley Library at: 10.1111/apt.14821
If you are the owner of this record, you can report an update to it here: Report update to this record